Drug intelligence / Profile preview

Elixicure

Development stage
Unknown
Lead developer
Honest Globe
Modality
Small Molecules
Administration
Topical
01

Overview

Elixicure is an over-the-counter (OTC) topical pain relief cream developed and manufactured by Honest Globe. The formulation is a combination product containing active ingredients such as menthol and camphor, supplemented with hemp-derived cannabidiol (CBD) extract. It is designed for the temporary relief of minor aches and pains associated with sore muscles and joints, arthritis, strains, bruises, and sprains. The product functions primarily as a counterirritant, utilizing menthol and camphor to create cooling and warming sensations that desensitize local nociceptors. Although marketed as an all-natural pain relief solution, Elixicure was the subject of a 2021 FDA warning letter regarding its status as an unapproved new drug and violations of Current Good Manufacturing Practice (CGMP) regulations, specifically noting that CBD is not a recognized active ingredient in the OTC Topical Analgesic Monograph.

Brand names
Elixicure
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Elixicure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elixicure.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call